BDH Industries (BOM:524828) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524828 BDH Industries Ltd BOM:524828
74 GF Score
Price ₹537.35
GF Value ₹393.14
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is BDH Industries FFO per Share?

FFO per Share only applies to REITs.

BOM:524828
74GF Score
BDH Industries Ltd BOM:524828
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BDH Industries (BOM:524828) Overvalued in 2026?

Based on GuruFocus' analysis, BDH Industries stock appears to be overvalued. The current stock price of ₹537.35 is trading 36.7% above its estimated GF Value™ of ₹393.14. GuruFocus considers BDH Industries to be Significantly Overvalued.

Key valuation signals for BOM:524828:

  • FFO per Share:
  • GF Value™: ₹393.14 vs. price of ₹537.35 (36.7% above fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the BOM:524828 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BDH Industries Business Description

Address Nair Baug, Akurli Road, Kandivli (East), Mumbai, MH, IND, 400101
BDH Industries Ltd is an India based pharmaceutical company. It is engaged in the manufacturing of therapeutic formulations including various pharmaceuticals. The company has the following reportable segments; Pharmaceuticals and Renewable Energy. The majority of its revenue is generated from the Pharmaceuticals segment. The company's product portfolio encompasses therapeutic categories including antifungal, antibiotics, anticancer, antidiabetic, antidepressant, antiulcerant, antimalarials, anti-inflammatory, analgesic, antispasmodic, anti-tuberculosis, cardiovascular, dermatological, psychotropic, and others.
74GF Score

Get the complete analysis for BOM:524828

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹537.35
Price
₹393.14
GF Value